Lifeward Ltd. reported that at its Extraordinary General Meeting on March 12, 2026, shareholders approved the issuance of Ordinary Shares to Oramed Pharmaceuticals Inc. as part of the acquisition of Oratech Pharma, Inc. This strategic move is expected to enhance Lifeward's market position.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.